Packages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy.
Still, it's seen as too expensive for many public health systems in Europe.
They're obviously in a capacity constrained environment and we don't know how much they're willing to allocate to Europe.
Eli Lily , whose diabetes drug Mounjaro can also be used for weight loss, has also faced supply gluts.
They're obviously in a capacity constrained environment and we don't know how much they're willing to allocate to Europe," Field said.
Persons:
Stefan Trumpf, it's, Emily Field, Wegovy's, Eli Lily
Organizations:
Novo Nordisk, Getty, CNBC, Denmark — Novo, Barclays, BMI, German Obesity Society, Novo Nordisk —
Locations:
Danish, Germany, Europe, Denmark, Norway, Novo, U.S